Ask an AI diet app to log a home-cooked South Indian thali and it may guess wrong — not because the algorithm is broken, but because it was never trained on the right data. That documented limitation, confirmed in peer-reviewed research published just this year, will be among the live questions when more than 1,650 scientific presentations converge at NUTRITION 2026, the flagship annual meeting of the American Society for Nutrition (ASN), opening this Saturday at the Gaylord National Resort & Convention Center in National Harbor, Maryland.
The four-day meeting — running July 25–28 just outside Washington, DC — will bring together researchers, clinicians, public health officials, and federal regulators at a moment when nutrition science is under unusually high public and political scrutiny. The 2025–2030 Dietary Guidelines for Americans were released in January 2026 under conditions of significant scientific controversy, and the NUTRITION 2026 plenary session on Saturday afternoon will mark the first major organized gathering of the scientific community to formally examine what the evidence supports — and where the process went wrong. Infant formula regulation is being overhauled for the first time in four decades under Operation Stork Speed, GLP-1 weight-loss and diabetes drugs now reach tens of millions of patients globally with critical nutritional management questions still unanswered, and AI-powered diet tools are moving into clinical use before their accuracy and equity limitations are fully understood.
The conference runs daily from July 25 to July 28, with a pre-conference workshop on Thursday, July 24. All session times below are Eastern Time (ET)
Thursday Preview: AI and Precision Nutrition Workshop
Before the main conference opens, a pre-conference workshop on Thursday afternoon will introduce attendees to the engineering architecture behind the federal government’s most ambitious AI nutrition research program. The session, titled “AI and Precision Nutrition: Introduction to the All of Us Researcher Workbench,” is co-sponsored by the NIH Office of Nutrition Research, ASN, the Academic Nutrition Departments and Programs (ANDP), and the Cornell Joan Klein Jacobs Center for Precision Nutrition and Health, and will be chaired by Dr. Saurabh Mehta, MBBS, ScD, Director of the Cornell center.
Participants will learn to navigate the NIH All of Us Researcher Workbench, the cloud-based data platform into which the Nutrition for Precision Health (NPH) study is loading its results. The NPH program, launched with $170 million in NIH funding, is enrolling 10,000 participants from diverse backgrounds to generate AI algorithms that can predict how individual people respond to specific foods — linking genetics, electronic health records, wearable sensor data, and dietary surveys into a unified prediction model. The Workbench itself is hosted on a cloud architecture developed by the US Military Academy’s AIDE-ML Center at West Point, which built the “Data Distiller for Precision Nutrition” — a pipeline that collapses multi-stream data into AI-ready datasets. Participants will need a working knowledge of R and must bring a laptop.
Saturday, July 25: Opening Day
Food as Medicine: Clinical Evidence for Produce Prescriptions and Tailored Meals (8:30–9:30 a.m.)
The conference will open with a session examining produce prescription programs and medically tailored meal interventions across healthcare settings. These programs have expanded rapidly inside Medicaid waiver programs and major insurer pilots, making them a multibillion-dollar policy question. The session draws on results from clinical trials and pragmatic studies to help clinicians, health systems, and policymakers distinguish which food-as-medicine strategies produce measurable clinical benefit, for which patient populations, and in which care settings.
Nutritional Drivers of Cognitive Decline and Chronic Disease in Aging Populations (8:30–9:30 a.m.)
A concurrent session will present new findings from longitudinal cohort studies and randomized controlled trials examining how diet affects cognitive decline and chronic disease risk as the population ages. It addresses what many clinicians describe as one of the most poorly individualized questions in preventive medicine
Ultra-Processed Foods and Meal Timing: What Both Do to Your Metabolism (10:00–11:30 a.m.)
New research on ultra-processed foods (UPFs) and time-restricted eating will arrive at a moment when the scientific definition of “ultra-processed” itself is contested. The FDA and USDA began a formal process in 2025 to develop a uniform federal UPF definition, after years in which researchers relied on the NOVA classification system (developed by Monteiro and colleagues in 2010) while the food industry disputed it. The session will examine both what we eat and when we eat it, presenting evidence on whether meal timing independently influences metabolic health outcomes beyond the effects of dietary content alone.
Dietary Guidance at a Crossroads: First Scientific Response to Contested Dietary Guidelines (2:30–4:30 p.m.)
This is the session that makes NUTRITION 2026’s Washington, DC location more than symbolic. The 2025–2030 Dietary Guidelines for Americans — which shape school lunch programs, SNAP benefits, WIC, and clinical guidance for hundreds of millions of Americans — were released on January 7, 2026 under conditions that scientists described as unprecedented in the guidelines’ 45-year history. For the first time since 1980, the standard Dietary Guidelines Advisory Committee process was bypassed; a separate review panel produced the final recommendations, which departed significantly from what the independent DGAC had proposed.
The result was a guidelines document featuring an inverted pyramid graphic emphasizing steak, full-fat dairy, and butter — even while retaining the longstanding 10% caloric limit on saturated fat, a contradiction that Harvard’s Nutrition Source, from the department chaired by Dr. Frank Hu at the T.H. Chan School of Public Health, described as producing “mixed messaging” that could lead to confusion and potentially higher intake of saturated fat and increased cardiovascular risk. The Center for Science in the Public Interest called the report “insufficient” and published its own alternative guidelines. A Stanford Medicine analysis flagged protein overemphasis and fiber downplay.
The NUTRITION 2026 plenary will convene speakers to examine how nutrition evidence is translated into population-level guidance and how the scientific community can demand a more rigorous and transparent process going forward. In a format of short, high-impact talks, attendees will hear from researchers who have spent months dissecting what the January 2026 guidelines got right, what they got wrong, and what the mechanism of failure was. This is not a routine governance session. It is the first organized scientific reckoning with a politically charged process, held in the city where that process played out.
Gut Microbiome and Diet: Separating Signal from Consumer Marketing (4:30–6:00 p.m.)
A late-afternoon session will confront one of nutrition science’s most commercially exploited topics: the relationship between diet and the gut microbiome. Despite widespread marketing of “gut-friendly” foods and probiotic supplements, accumulated evidence suggests dietary shifts alone rarely produce large or durable changes in the overall composition of the gut microbiota. The session is expected to surface new research complicating the picture further while distinguishing what the science actually shows from what consumer brands claim.
Sunday, July 26
How Much Protein Do We Actually Need? (10:30 a.m.–noon)
Protein intake is among the most commercially amplified topics in popular nutrition, and the science has not caught up with the marketing. This session will examine what researchers, clinicians, and policymakers should actually use to set protein intake guidance — including where existing Dietary Reference Intakes (DRIs) fall short. The session has particular clinical urgency because of the explosive growth in GLP-1 drug prescriptions: semaglutide (Wegovy), tirzepatide (Zepbound), and the newly approved oral orforglipron (Foundayo, cleared by the FDA in April 2026 at $149 per month for self-pay patients) all suppress appetite in ways that increase the risk of inadequate protein intake and lean mass loss. A 2025 joint nutrition advisory from the American Society for Nutrition and three partner organizations, presented at the American Diabetes Association’s June 2026 Scientific Sessions in New Orleans, recommended protein targets of 1.5 grams per kilogram (0.68 grams per pound) of body weight daily for GLP-1 patients — a target that is frequently missed by patients whose appetites are suppressed.
Menopause, Nutrition, and the Microbiome: Filling a Research Gap (10:30 a.m.–noon)
A concurrent session will take on an area of women’s health chronically underrepresented in nutrition research. The menopause transition is now understood to carry implications for metabolic function, cognitive performance, gut microbiome composition, and cardiometabolic disease risk, yet nutrition guidance for menopausal women remains limited. Experts will assess current evidence gaps and offer future research directions — filling a space that consumer wellness companies have rushed to fill with products running well ahead of the science.
GLP-1 Drugs Across Adolescents, Older Adults, and Other Special Populations (2:30–4:00 p.m.)
The session most likely to change clinical practice arrives Sunday afternoon. GLP-1 receptor agonists have transformed the treatment of obesity and type 2 diabetes — enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and increasing satiety through a class B G-protein-coupled receptor expressed primarily in the pancreatic islets, brain, and GI tract. The vast majority of clinical trial data, however, comes from middle-aged adults. This session will examine what happens when these drugs are used in adolescents, whose prescription rate increased from 0.12% to 1.38% of teens with obesity between December 2022 and July 2025, and in older adults, where frailty risk and lean mass preservation become clinically dominant concerns.
Experts will address nutritional complications — protein deficiency and micronutrient gaps — that clinicians are encountering in long-term GLP-1 users, and will present practical guidance for managing patients whose dietary intake has been dramatically reduced by the drugs’ appetite-suppressing effects. About half of GLP-1 patients discontinue treatment within a year, and the session will address the nutritional and clinical transitions that discontinuation requires
Read more:GLP-1 Drugs 2026: ADA Sessions Close as New Standards End Single-Goal Diabetes Care
Competing Nutrition Goals in Older Adults: Clinical Frameworks for Conflict (4:30–5:30 p.m.)
For aging patients, nutrition goals frequently conflict: reducing caloric intake to manage cardiometabolic risk may directly undermine the protein and caloric adequacy needed to preserve muscle mass and prevent frailty. This session provides clinicians with practical frameworks for navigating those tradeoffs, and forms part of ASN’s From Research to Practice clinical track, which carries continuing education credit for registered dietitians
Monday, July 27
Food Production, Processing, and What Arrives on Your Plate (8:30–9:30 a.m.)
Emerging evidence is beginning to establish links between how food is grown and processed — not merely what it contains — and its nutritional value by the time it is consumed. This session presents new findings on the relationships between agricultural management practices, post-harvest handling, food processing, and the nutritional composition of the final product. The implications for dietary guidance are significant: if production methods affect nutritional quality independently of nutrient composition, existing nutrient-centric guidelines may be systematically incomplete.
Ultra-Processed Foods and Chronic Disease: The Regulatory and Definitional Debate (10:30 a.m.–noon)
Monday’s UPF session will go deeper than Saturday’s metabolism focus, bringing together researchers from NIH, USDA, and FDA to confront the definitional debate directly. The central question is mechanistic and policy-significant: does UPF consumption drive chronic disease through nutritional quality (the saturated fat, sodium, and added sugar it tends to contain), or through something inherent to industrial processing itself — the food matrix disruption, the artificial emulsifiers, the ultra-fast digestibility — that causes excess energy intake independently of nutrient profile? The answer will directly shape whether future dietary guidance can be built around nutrient limits, or whether processing methods themselves need to become a regulatory category.
Are AI Diet Apps Accurate for Everyone? Not Yet (2:30–4:00 p.m.)
This is the session most directly affecting any reader who has used a smartphone app to log food or received dietary coaching from an AI chatbot. A 2025 systematic review in the British Journal of Nutrition (Cofre et al.) found that 61.5% of evaluated studies testing AI dietary assessment tools were conducted in preclinical settings, with 58.3% exhibiting moderate risk of bias; the six studies that showed correlation coefficients above 0.7 between AI tools and traditional dietary methods achieved those results in controlled laboratory conditions, not real-world use. A 2026 study in Frontiers in Digital Health found that AI dietary tools systematically underestimate energy intake in multicultural populations because they are trained overwhelmingly on Western food databases — causing them to misidentify or mis-portion dishes from South Asian, African, Latin American, and East Asian cuisines.
A 2026 narrative review in Global Perspectives on Nutrition confirmed this finding, noting that underrepresentation in training data leads to reduced accuracy, systematic underestimation of energy intake, and poor generalizability in multicultural populations. The FDA’s 2025 draft guidance for AI-enabled medical devices explicitly requires sponsors to demonstrate that algorithms perform consistently across demographic groups before seeking regulatory clearance. Current AI dietary tools, the literature indicates, are not validated for unsupervised use in patients with metabolic disorders such as obesity.
This session will address best practices for model training, validation, and privacy protection. Scientific Program Committee member Stephen R. Hennigar, PhD, has identified AI and dietary assessment as among the most important topics at this year’s meeting
Optimizing Nutrition During Pregnancy and Early Childhood (10:30 a.m.–noon)
Nutritional exposures during pregnancy and the first years of life carry outsized consequences for long-term health. This session will present new research on opportunities to optimize nutrition across this critical developmental window, covering both dietary interventions and the role of environmental exposures that interact with nutritional status during fetal development and early childhood
Child Undernutrition and Social Protection: Breaking Down Silos (Monday, time TBD)
Also on Monday, a session on global child nutrition will examine how cash transfers, school feeding initiatives, and nutrition-sensitive agriculture programs can serve as delivery platforms for nutritional interventions — reflecting ASN’s growing emphasis on the intersection of food systems, economic inequality, and nutritional outcomes
Tuesday, July 28: Closing Day
Beyond GLP-1s: Amylin and Glucagon Combinations in Next-Generation Obesity Drugs (10:00–11:30 a.m.)
The drug pipeline for obesity is moving rapidly past GLP-1 mechanisms alone. This session will examine the pharmacology of the next generation of obesity medicines, with a focus on amylin and glucagon signaling pathways. Novo Nordisk’s cagrilintide/semaglutide combination (CagriSema), currently awaiting FDA decision, produced a mean weight loss of 22.7% at 68 weeks in the REDEFINE 1 trial, with more than 40% of participants achieving at least a 25% reduction in body weight — substantially exceeding what semaglutide alone produces. The session will cover amylin analogs, glucagon receptor agonists, and the emerging rationale for combining mechanisms to address the limitations of single-pathway drugs.
Infant Formula Still Lacks US Heavy Metal Limits: Operation Stork Speed Session (10:00–11:30 a.m.)
Few sessions at NUTRITION 2026 carry a clearer consumer protection message. The nutritional standards governing US infant formula have remained largely unchanged since the 1980s. Consumer Reports tests found that some infant formula products contain potentially harmful levels of arsenic and lead, and the US — unlike the European Union, Australia, and Canada — has not established enforceable maximum allowable levels for heavy metals in infant formula. Approximately 86% of US infants have ever received breast milk, but only about 28% are exclusively breastfed through six months of age as recommended by the American Academy of Pediatrics, meaning the majority of US infants are at least partially formula-dependent during the period of highest vulnerability to neurotoxic heavy metal exposure.
Operation Stork Speed, the joint HHS-FDA initiative launched on March 18, 2025, has begun implementation this year. In 2026, the FDA is developing a plan for modernizing infant formula nutrient requirements and will release exposure data on lead, arsenic, cadmium, mercury, and PFAS. This session will feature contributors to that initiative, examining the path from the June 2025 expert panel’s recommendations — which called for streamlined FDA approval processes, greater transparency in GRAS ingredient safety determinations, and stronger environmental contaminant limits — toward regulatory modernization.
Beyond the Label: Food Additive Safety in the Regulatory Spotlight (8:30–9:30 a.m.)
Food additives sit at the center of one of the most politically charged nutrition debates in years. The Trump administration’s “Make America Healthy Again” initiative and HHS Secretary Robert F. Kennedy Jr.’s focus on food dyes and additives have accelerated regulatory scrutiny. This session will examine what additives actually are, why they are used, how safety is evaluated, and what the evolving regulatory landscape means for the food industry and for public health. The session does not start from the premise that additives are harmful or safe — it starts from the evidence.
Embedding Nutrition Education in Medical Training (8:30–9:30 a.m.)
The US Department of Health and Human Services has expanded efforts to integrate nutrition education into medical school curricula. This session addresses the strategies and institutional structures needed to achieve a systemic transformation of how physicians learn about nutrition — a gap that advocates argue is structurally responsible for the nation’s healthcare system’s failure to move meaningfully toward prevention
Presidential Symposium: One Health in a Global Context
Throughout the meeting, the Presidential Symposium curated by ASN President Naima Moustaid-Moussa, PhD, will take a planetary view of nutrition science. Featuring international leaders from CGIAR and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), the symposium will examine how climate-resilient agriculture, diversified food systems, and locally driven solutions translate into better diets and improved health outcomes for women and children in climate-stressed settings. The “One Health” framework — integrating human, animal, and environmental health as interconnected — is gaining regulatory traction in both nutrition science and global health policy.
Connect with the Fed Sessions
“Connect with the Fed” sessions will provide direct access to leaders from FDA, USDA, NIH, and the Centers for Disease Control and Prevention. These sessions are unusually valuable this year: regulatory change at all four agencies is accelerating, from the Operation Stork Speed implementation to the FDA/USDA UPF definition process to the contested Dietary Guidelines revision cycle that the January 2026 guidelines have already reopened
Does Your Diet App Know What You’re Actually Eating?
The AI dietary assessment session on Monday (2:30–4:00 p.m.) surfaces a limitation that affects everyone who uses a nutrition tracking app: the tools were largely built on databases assembled from Western dietary contexts, and they perform measurably worse on foods that fall outside those contexts. A patient who primarily eats foods derived from South Asian, African, East Asian, or Latin American cuisines may receive systematically incorrect caloric and nutrient estimates from the apps their clinicians recommend.
This is not a minor accuracy gap. It is a structural equity problem in a technology that is moving toward clinical integration. Research published in 2026 in two separate peer-reviewed journals confirms that underrepresentation in training data leads to reduced accuracy, systematic underestimation of energy intake, and poor generalizability in multicultural populations. The Monday session will examine validation standards, equity requirements, and privacy frameworks that responsible deployment requires. The FDA’s 2025 draft guidance explicitly requires demographic consistency demonstration — but that requirement applies only to devices seeking regulatory clearance, not to the consumer apps already in use.
Frequently Asked Questions
Are AI-powered diet tracking apps accurate for non-Western foods?
Not reliably. A 2025 systematic review in the British Journal of Nutrition (Cofre et al.) found that AI dietary assessment tools achieved high accuracy only in controlled laboratory settings, not real-world use, and that the majority of validation studies were conducted in preclinical conditions with moderate bias risk. A 2026 study in Frontiers in Digital Health specifically documented that these tools systematically underestimate energy intake in multicultural populations because they are trained primarily on Western food databases. If your diet centers on foods from South Asian, African, East Asian, or Latin American cuisines, current AI apps may give you meaningfully inaccurate calorie and nutrient counts.
What is Operation Stork Speed, and why does it matter for parents of formula-fed infants?
Operation Stork Speed is the joint HHS-FDA initiative launched March 18, 2025, to overhaul US infant formula regulation, which has remained largely unchanged since the 1980s. Consumer Reports tests previously found that some infant formula products contained potentially harmful levels of arsenic and lead. Unlike the EU, Australia, and Canada, the US has no enforceable maximum levels for heavy metals in formula. In 2026, the FDA is developing a nutrient modernization plan and will release heavy metal and PFAS exposure data. The NUTRITION 2026 closing-day session on Tuesday will feature contributors to the expert panel that drove those changes.
If I’m taking a GLP-1 weight-loss drug, what should I know about protein?
GLP-1 drugs like semaglutide and tirzepatide suppress appetite significantly, which creates a real risk of inadequate protein intake — and GLP-1-driven weight loss includes lean muscle mass, not just fat. A 2025 joint nutrition advisory from ASN and three partner organizations recommended a protein target of 1.5 grams per kilogram (0.68 grams per pound) of body weight daily for GLP-1 patients — significantly higher than general dietary protein guidelines. The NUTRITION 2026 Sunday sessions on GLP-1 clinical management and protein requirements will address how to meet that target when appetite suppression makes eating adequate food difficult. About half of GLP-1 patients discontinue treatment within a year, which creates additional nutritional management needs that clinicians are still learning to anticipate.
What was controversial about the 2025–2030 Dietary Guidelines, and will NUTRITION 2026 address it?
The 2025–2030 Dietary Guidelines for Americans, released January 7, 2026, generated significant scientific criticism because the standard Dietary Guidelines Advisory Committee process was bypassed for the first time since 1980 — a separate review panel produced recommendations that departed substantially from what the independent DGAC proposed. The resulting guidelines featured visual emphasis on red meat, full-fat dairy, and butter that Harvard researchers said contradicted the retained 10% saturated fat limit, and were described by the Center for Science in the Public Interest as “insufficient.” The NUTRITION 2026 Saturday plenary (2:30–4:30 p.m. ET) will be the first major scientific gathering to formally examine that process and what it means for future dietary guidance.
ⓒ 2026 TECHTIMES.com All rights reserved. Do not reproduce without permission
Tags:NutritionAIPublic health
